Ashleigh Wee-Hee

ORCID: 0009-0004-3962-4256
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Vaccine Coverage and Hesitancy
  • Bacterial Infections and Vaccines
  • COVID-19 Impact on Reproduction
  • Immune responses and vaccinations
  • Emergency and Acute Care Studies
  • Pediatric health and respiratory diseases
  • Infective Endocarditis Diagnosis and Management
  • Pleural and Pulmonary Diseases

Murdoch Children's Research Institute
2022-2024

Peter Doherty Institute
2024

The University of Melbourne
2024

Royal Children's Hospital
2022-2024

Nonpharmaceutical interventions (NPIs) implemented to contain SARS-CoV-2 have decreased invasive pneumococcal disease. Previous studies proposed the decline is due reduced transmission or suppression of respiratory viruses, but mechanism remains unclear. We undertook a secondary analysis data collected from clinical trial evaluate impact NPIs on carriage and density, drivers disease, during COVID-19 pandemic in Ho Chi Minh City, Vietnam. Nasopharyngeal samples children aged 24 months were...

10.1128/spectrum.03615-22 article EN cc-by Microbiology Spectrum 2023-01-16

Streptococcus pneumoniae (the pneumococcus) is a human pathogen of global importance, classified into serotypes based on the type capsular polysaccharide produced. Serotyping pneumococci essential for disease surveillance and vaccine impact measurement. However, accuracy serotyping methods can be affected by previously undiscovered variants. Previous studies have identified variants serotype 14, highly invasive included in all licensed formulations. potential these to influence evade...

10.1128/spectrum.01524-22 article EN cc-by Microbiology Spectrum 2022-07-12

Limited data from Asia are available on long-term effects of pneumococcal conjugate vaccine introduction carriage. Here we assess the impact 13-valent (PCV13) nasopharyngeal carriage prevalence, density and antimicrobial resistance. Cross-sectional surveys were conducted pre-PCV13 (2015) post-PCV13 (2017 2022). Pneumococci detected quantified by real-time PCR swabs. DNA microarray was used for molecular serotyping to infer genetic lineage (Global Pneumococcal Sequence Cluster). The study...

10.1038/s41467-024-50944-3 article EN cc-by-nc-nd Nature Communications 2024-08-03

Pleural empyema is a serious complication of pneumonia in children. Negative bacterial cultures commonly impede optimal antibiotic therapy. To improve identification, we developed molecular assay and evaluated its performance compared with culture. Our multiplex-quantitative PCR to detect Streptococcus pneumoniae , pyogenes Staphylococcus aureus Haemophilus influenzae was assessed using genomic DNA laboratory-prepared samples (n = 267). evaluate clinical performance, conducted the Molecular...

10.1371/journal.pone.0304861 article EN cc-by PLoS ONE 2024-06-25

Background: Data on pneumococcal serotype changes in hospitalised children following conjugate vaccine (PCV) introduction low-middle income countries are limited. Mongolia introduced the 13-valent PCV (PCV13) into national immunisation programme from 2016. We measured effect of PCV13 nasopharyngeal carriage with pneumonia over a six-year period.Methods: Children aged 2-59 months (n=17,607) were enrolled during April 2015 to June 2021 four districts Ulaanbaatar. Nasopharyngeal swabs (n=6,545)...

10.2139/ssrn.4488943 preprint EN 2023-01-01
Laure F. Pittet Cecilia L. Moore Ellie McDonald Simone Barry Marc J. M. Bonten and 95 more John Campbell Júlio Croda Margareth Pretti Dalcolmo Andrew Davidson Mark W. Douglas Kaya Gardiner Amanda Gwee Bruno Araújo Jardim Marcus Lacerda Michaela Lucas Miriam A. Lynn Laurens Manning Roberto Dias de Oliveira Kirsten P. Perrett Cristina Prat Peter Richmond Jorge L. Rocha Jesús Rodríguez‐Baño Adilia Warris Nick Wood Nicole L. Messina Nigel Curtis Nigel Curtis Andrew Davidson Kaya Gardiner Amanda Gwee Tenaya Jamieson Nicole L. Messina Thilanka Morawakage Susan Perlen Kirsten P. Perrett Laure F. Pittet Amber Sastry Jia Wei Teo Francesca Orsini Katherine Lee Cecilia L. Moore Suzanna Vidmar Laure F. Pittet Rashida Ali Ross Dunn Peta Edler Grace Gell Casey Goodall Richard Hall Ann Krastev Nathan La Ellie McDonald Nick McPhate Thao T. Nguyen Jack Ren Luke Stevens Nicole L. Messina Ahmed Alamrousi Rhian Bonnici Thanh Duc Dang Susie Germano Jenny Hua Rebecca McElroy Monica Razmovska Scott J. J. Reddiex Xiaofang Wang Jeremy Anderson Kristy Azzopardi Vicki Bennett‐Wood Anna Czajko Nadia Mazarakis Conor McCafferty Frances Oppedisano Belinda D. Ortika Casey L. Pell Leena Spry Ryan Toh Sunitha Velagapudi Amanda Vlahos Ashleigh Wee-Hee Pedro M. Ramos Karina De La Cruz Dinusha Gamage Anushka Karunanayake Isabella Mezzetti Benjamin Ong Ronita Singh Enoshini Sooriyarachchi Suellen Nicholson Natalie Cain Rianne Brizuela Han Hsiang Huang Veronica Abruzzo Morgan Bealing Patricia Bimboese Kirsty Bowes Emma Burrell Joyce Chan Jac Cushnahan

BackgroundRecurrences of herpes simplex virus (HSV) in the orofacial region (herpes labialis or cold sores) impact quality-of-life. We aimed to study whether bacille Calmette-Guérin (BCG) vaccine can attenuate sore recurrences through off-target immunomodulatory effects.MethodsIn this nested randomised controlled trial within multicentre, phase 3 BRACE trial, 6828 healthcare workers were 36 sites Australia, Netherlands, Spain, United Kingdom and Brazil, receive BCG-Denmark no BCG (1:1 ratio...

10.1016/j.eclinm.2023.102203 article EN cc-by EClinicalMedicine 2023-09-11

Abstract Non-pharmaceutical interventions (NPIs) implemented to contain SARS-CoV-2 have decreased invasive pneumococcal disease. We undertook an observational study evaluate the impact of NPIs on carriage and density, drivers transmission disease, during COVID-19 pandemic in Ho Chi Minh City, Vietnam. While did not significantly carriage, mean capsular density by up 91.5% (1.07 log 10 genome equivalents/mL, 95% Confidence Interval: 0.74-1.41) after NPI introduction compared with pre-COVID-19...

10.1101/2022.05.05.22274646 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-05-07
Coming Soon ...